Zambia Pharmaceuticals and Healthcare Report Q1 2013
1/16/2013 | published by: Business Monitor International
... by both NGOs and international investors as a sign that Zambia istaking its commitment to healthcare seriously. The country suffers from a burden of both communicableand non-communicable diseases, with a high incidence of HIV and ...
|
more...
|
$1,175.00
|
Morocco Pharmaceuticals and Healthcare Report Q1 2013
1/16/2013 | published by: Business Monitor International
... the evidence ofbribery and corruption, and the shortage of doctors in the sector. BMI believes the commitment toimprove governance and implement controls in the sector will be fulfilled in the medium-to-long term. Assuch, we maintain ...
|
more...
|
$1,175.00
|
Sudan and South Sudan Pharmaceuticals and Healthcare Report Q1 2013
1/2/2013 | published by: Business Monitor International
... non-oil economies. Political risk remains elevated as many disputesbetween them are still unresolved. These macroeconomic uncertainties will mean lack of focus on publichealthcare provision, which further complicates the problem that the general population are unable ...
|
more...
|
$1,175.00
|
Gabon Pharmaceuticals and Healthcare Report Q1 2013
1/2/2013 | published by: Business Monitor International
... and the vast majority of expenditure will be on low-marginessential medicines. Due to tepid economic growth, our outlook for Gabon's pharmaceutical market isbelow that expected to be posted by many of its sub-Saharan Africa neighbours. ...
|
more...
|
$1,175.00
|
Healthcare, Regulatory and Reimbursement Landscape - South Africa
12/28/2012 | published by: GlobalData
... the South African healthcare, regulatory and reimbursement landscape, this report identifies the key trends in the healthcare market, as well as providing insights on the demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, ...
|
more...
|
$1,995.00
|
Botswana Pharmaceuticals and Healthcare Report Q1 2013
12/26/2012 | published by: Business Monitor International
... and healthcare companies, it is unlikely that the gap inhealthcare provision will be filled by private healthcare firms. We continue to maintain that given therelatively small pharmaceutical and healthcare market in Botswana, we do not ...
|
more...
|
$1,175.00
|
Cote d'Ivoire Pharmaceuticals and Healthcare Report Q1 2013
12/26/2012 | published by: Business Monitor International
... Cuban pharmaceutical firms revealing plans to set upplants in the country. But private investment is the exception, rather than the rule, in the country, withCôte d'Ivoire depending upon historical ties with France, Morocco and Tunisia ...
|
more...
|
$1,175.00
|
Cameroon Pharmaceuticals and Healthcare Report Q1 2013
12/12/2012 | published by: Business Monitor International
... the overall low pharmaceutical expenditure. Thesituation is further complicated by poor intellectual property protection, slow approval processes andrampant corruption. Consequently we do not expect the market to be of significant interest tomultinational pharmaceutical firms. Headline ...
|
more...
|
$1,175.00
|
Tanzania Pharmaceuticals and Healthcare Report Q1 2013
12/12/2012 | published by: Business Monitor International
... increase. However, we are concerned by the continued reliance onforeign grants and concessional loans. Headline Expenditure Projections Pharmaceuticals: TZS340.1bn (US$214mn) in 2011 to an expected TZS406.0bn(US$257mn) in 2012; +19.4% growth in local currency terms and ...
|
more...
|
$1,175.00
|
Angola Pharmaceuticals and Healthcare Report Q1 2013
12/12/2012 | published by: Business Monitor International
... investors, Dos Santos’ re-election will ensure political stabilityand continuity. Consequently a ‘business-as-usual’ attitude exists. The election results have not alteredour market forecasts for Angola’s healthcare and pharmaceutical market. While we expect that there willbe an ...
|
more...
|
$1,175.00
|
|
|
$2,500.00
|
Uganda Pharmaceuticals and Healthcare Report Q1 2013
12/12/2012 | published by: Business Monitor International
... both the rewards and the risks present ina market. With regards to assessing risks in the Ugandan healthcare sector, we have identified industryspecific dangers (such as low per-capita spending and poor access to healthcare facilities) ...
|
more...
|
$1,175.00
|
|
|
$2,500.00
|
Vitamins & Minerals – South Africa – a snapshot (2012)
12/6/2012 | published by: Mintel - Snapshots
... require prescriptions but includes pharmacy approved. Market size comprises sales through all retail channels including direct to consumer. Market size for Vitamins & Minerals in South Africa is given in ZAR with a minimum of ...
|
more...
|
$600.00
|
Healthcare, Regulatory and Reimbursement Landscape - Morocco
11/30/2012 | published by: GlobalData
... healthcare, regulatory and reimbursement landscape, this report identifies the key trends in the Morocco healthcare market, as well as providing insights on the demographic, regulatory, and reimbursement landscape, and the healthcare infrastructure of Morocco. Most ...
|
more...
|
$1,995.00
|
|
|
$3,500.00
|
Pharmaceuticals in South Africa
11/21/2012 | published by: MarketLine
... financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the South Africa pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, ...
|
more...
|
$350.00
|
|
|
$2,500.00
|
|
|
$2,500.00
|
South Africa Pharmaceuticals and Healthcare Report Q4 2012
11/14/2012 | published by: Business Monitor International
... deep segregation betweenprivate and public healthcare facilities continues to leave the vast majority of the population withoutmedical care. BMI believes this will be rectified through the creation of the National Health Insurancescheme over the next ...
|
more...
|
$995.00
|
Incontinence in Morocco
11/8/2012 | published by: Euromonitor International
... in disposable income levels was not merely seen amongst the working population, with a growing number of older consumers retiring on generous pensions. This trend therefore increased the number of consumers who might potentially require ...
|
more...
|
$900.00
|
Medicated Skin Care in Egypt
11/2/2012 | published by: Euromonitor International
... the potential consumer base for nappy (diaper) rash treatments. While the revolution in 2011 resulted in a slight drop in the birth rate in the year, it remained considerably higher than that seen at the ...
|
more...
|
$900.00
|
NRT Smoking Cessation Aids in Egypt
11/2/2012 | published by: Euromonitor International
... in chemists/pharmacies. Euromonitor International's NRT Smoking Cessation Aids in Egypt report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, ...
|
more...
|
$900.00
|
Cough, Cold and Allergy (Hay Fever) Remedies in Egypt
11/2/2012 | published by: Euromonitor International
... more careful in their spending patterns. However, volume growth remained strong, with the leading product areas cough remedies and medicated confectionery for example seeing 6% and 8% volume growth respectively. This was largely thanks to ...
|
more...
|
$900.00
|
Digestive Remedies in Egypt
11/2/2012 | published by: Euromonitor International
... rates remained strong, with this linked to ongoing strict price controls. While high inflation resulted in soaring prices for most fast-moving consumer goods in Egypt, price controls for medicines are not inflation-linked. Antacids and paediatric ...
|
more...
|
$900.00
|